Long-Term Performance of the Magmaris Drug-Eluting Bioresorbable Metallic Scaffold in All-Comers Patients' Population.

MLA

Al Nooryani, Arif, et al. “Long-Term Performance of the Magmaris Drug-Eluting Bioresorbable Metallic Scaffold in All-Comers Patients’ Population.” Journal of Clinical Medicine, vol. 11, no. 13, July 2022, p. 3726–N.PAG. EBSCOhost, https://doi.org/10.3390/jcm11133726.

APA

Al Nooryani, A., Aboushokka, W., AlBaba, B., Kerfes, J., Abudaqa, L., Bhatia, A., Mansoor, A., Nageeb, R., Aleksandric, S., & Beleslin, B. (2022). Long-Term Performance of the Magmaris Drug-Eluting Bioresorbable Metallic Scaffold in All-Comers Patients’ Population. Journal of Clinical Medicine, 11(13), 3726–N.PAG. https://doi.org/10.3390/jcm11133726

Chicago

Al Nooryani, Arif, Wael Aboushokka, Bassam AlBaba, Jalal Kerfes, Loai Abudaqa, Amit Bhatia, Anoop Mansoor, Ruwaide Nageeb, Srdjan Aleksandric, and Branko Beleslin. 2022. “Long-Term Performance of the Magmaris Drug-Eluting Bioresorbable Metallic Scaffold in All-Comers Patients’ Population.” Journal of Clinical Medicine 11 (13): 3726–N.PAG. doi:10.3390/jcm11133726.